Literature DB >> 16782308

Recurrence related to treatment modalities of unicystic ameloblastoma: a systematic review.

S L Lau1, N Samman.   

Abstract

This systematic review aims to identify all studies pertinent to the clinical question, 'which treatment for unicystic ameloblastoma results in the lowest recurrence rate?' A structured systematic search of the literature, with predefined inclusion and exclusion criteria, using computer and manual searches as well as personal communication, was performed. Evaluations and critical appraisal were done separately in 3 rounds. All searches were performed by 2 independent judges and any disagreement was settled by discussion with a third party. Four treatment modalities for unicystic ameloblastomas were identified. The recurrence rates were 3.6% for resection, 30.5% for enucleation alone, 16% for enucleation followed by application of Carnoy's solution and 18% for marsupialization with/without other treatment in a second phase. It was concluded that there is only weak evidence showing that jaw resection resulted in the lowest recurrence rate, followed by enucleation with application of Carnoy's solution. Enucleation alone resulted in the highest recurrence rate and treatment by marsupialization cannot be sufficiently evaluated since most cases were followed by a second stage surgery of some kind.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782308     DOI: 10.1016/j.ijom.2006.02.016

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN: 0901-5027            Impact factor:   2.789


  34 in total

1.  A review of literature on ameloblastoma in children and adolescents and a rare case report of ameloblastoma in a 3-year-old child.

Authors:  Zainab Chaudhary; Sriram Krishnan; Pankaj Sharma; Rakesh Sharma; Priya Kumar
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2012-09

2.  Conservative Management of Unicystic Ameloblastoma in Young Patients: A Prospective Single-Center Trial and Review of Literature.

Authors:  Mitsu Meshram; Lalit Sagarka; Jigar Dhuvad; Sonal Anchlia; Siddharth Vyas; Harsh Shah
Journal:  J Maxillofac Oral Surg       Date:  2016-12-20

3.  Difficulties in the diagnosis of plexiform ameloblastoma.

Authors:  Igor Iuco Castro-Silva; Monica Simoes Israel; Glauco Siqueira Lima; Simone de Queiroz Chaves Lourenço
Journal:  Oral Maxillofac Surg       Date:  2011-03-01

4.  The management of aggressive cysts of the jaws.

Authors:  Paul J W Stoelinga
Journal:  J Maxillofac Oral Surg       Date:  2012-03-11

5.  Unresectable Ameloblastoma Successfully Treated with Definitive Proton Therapy.

Authors:  Francesco Dionisi; Maurizio Amichetti; Carlo Algranati; Irene Giacomelli; Mattia Barbareschi; Mauro Recla; Cesare Grandi
Journal:  Int J Part Ther       Date:  2017-09-26

6.  Conservative management of unicystic ameloblastoma in a young child: Report of two cases.

Authors:  Ritesh Kalaskar; Ashok S Unawane; Ashita R Kalaskar; Prashant Pandilwar
Journal:  Contemp Clin Dent       Date:  2011-10

Review 7.  Ameloblastoma: a clinical review and trends in management.

Authors:  Andrew C McClary; Robert B West; Ashley C McClary; Jonathan R Pollack; Nancy J Fischbein; Christopher F Holsinger; John Sunwoo; A Dimitrios Colevas; Davud Sirjani
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-04-30       Impact factor: 2.503

8.  Carnoy's in Aggressive Lesions: Our Experience.

Authors:  B P Rajeshkumar; Kirthi Kumar Rai; N T Geetha; H R Shivakumar; Amarnath P Upasi
Journal:  J Maxillofac Oral Surg       Date:  2012-04-04

9.  Unicystic ameloblastoma of the mandible--an unusual case report and review of literature.

Authors:  Rakesh S Ramesh; Suraj Manjunath; Tanveer H Ustad; Saira Pais; K Shivakumar
Journal:  Head Neck Oncol       Date:  2010-01-14

10.  Two stage enucleation and deflation of a large unicystic ameloblastoma with mural invasion in mandible.

Authors:  Ryo Sasaki; Yorikatsu Watanabe; Tomohiro Ando; Tanetaka Akizuki
Journal:  Craniomaxillofac Trauma Reconstr       Date:  2014-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.